Zydus Lifesciences moves up on getting PAS approval from USFDA for Mycophenolate Mofetil for Injection
Zydus Lifesciences is currently trading at Rs. 376.20, up by 3.00 points or 0.80% from its previous closing of Rs. 373.20 on the BSE. The scrip opened at Rs. 375.00 and has touched a high and low of Rs. 376.20 and Rs. 373.00 respectively. So far 1701 shares were traded on the counter. The BSE … Read more
